Zilretta (triamcinolone acetonide extended-release injectable suspension) is a specialized type of corticosteroid injection designed specifically for managing osteoarthritis pain in the knee. Unlike traditional steroid shots that dissolve quickly, Zilretta uses advanced technology to provide pain relief that lasts longer.
Traditional steroid injections peak rapidly and then leaves the joint within a few days. Zilretta uses microsphere technology to change this delivery method.
Extended Release: The medication is embedded in tiny, biodegradable microspheres made of a polymer used in dissolvable sutures.
Localized Stay: These microspheres stay within the knee joint, slowly releasing the medicine over several weeks rather than all at once.
Lower Systemic Absorption: Because the medicine is released slowly and stays mostly within the joint, less of it enters the bloodstream compared to standard injections.
Zilretta was developed to address the common complaints patients have regarding standard cortisone shots.
Longer Duration of Relief: In clinical trials, many patients experienced significant pain relief for up to 12 to 16 weeks.
Better Blood Sugar Management: Standard steroids often cause a spike in blood sugar, which is a major concern for diabetic patients. Clinical data suggests Zilretta has a smaller impact on blood glucose levels.
Consistent Pain Control: By providing a steady "trickle" of medication, patients often avoid the roller coaster of feeling great for two weeks and then having the pain return abruptly.
While Zilretta offers distinct advantages, it is still a corticosteroid and carries some of the same general risks.
Specific to the Knee: Currently, Zilretta is only FDA-approved for use in the knee joint. It is not indicated for use in the shoulder, hip, or other areas.
Single Use Focus: It is intended for a single injection per flare-up. Research is ongoing regarding the safety and efficacy of repeated Zilretta injections.
Common Side Effects: The most frequent side effects reported include joint pain, headache, and localized swelling at the injection site.
Not a Cure: Like all steroid treatments, Zilretta treats the symptoms of inflammation and pain but does not regrow cartilage or cure the underlying osteoarthritis.
This treatment is often a good choice for patients with knee osteoarthritis who find that standard injections wear off too quickly or for those who need to be more cautious about their blood sugar levels.